Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Hypothesis: Treatment with Glatiramer acetate prevents deterioration of gait in multiple sclerosis (MS) patients. During the study patients will undergo a 3 dimensional gait analysis before starting treatment with glatiramer acetate and after 1 year of treatment.
Epistemonikos ID: 29928bcaa562dabaeb55a60873768646d95e7342
First added on: May 04, 2024